Orange Book product · Brand (NDA)
EDLUAR
ZOLPIDEM TARTRATE
At a glance
Mar 13, 2009
Approved
Brand (NDA)
Application
AB
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 13, 2009
17 yr 6 mo ago
Today
Patent 9597281 expires
Listed method-of-use patent (U-674) expiration.
Apr 06, 2027
in 10 mo
Patent 9265720 expires
Listed method-of-use patent (U-674) expiration.
Feb 25, 2031
in 4 yr 9 mo
Pharmaceutical detail
Active ingredient
ZOLPIDEM TARTRATE
Strength
5MG
Dosage form
TABLET
Route
SUBLINGUAL
TE code
AB
Application
NDA 021997
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023ZOLPIDEM TARTRATEBrand (NDA)
NDA 215721 · ALMATICA
- 2011INTERMEZZOBrand (NDA)
NDA 022328 · PURDUE PHARMA
- 2008ZOLPIMISTBrand (NDA)
NDA 022196 · AYTU
- 2007TOVALT ODTBrand (NDA)
NDA 021412 · BIOVAIL LABS INTL
- 2005AMBIEN CRBrand (NDA)
NDA 021774 · COSETTE
- 1992AMBIENBrand (NDA)
NDA 019908 · COSETTE
- 2026ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 220717 · UMEDICA LABS PVT
- 2020ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 213592 · BRECKENRIDGE
- 2017ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 204229 · PH HEALTH
- 2017ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 204170 · SUN PHARM
- 2016ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 204503 · DR REDDYS
- 2016ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 202657 · PHARMOBEDIENT
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9597281 | Apr 06, 2027 | in 10 mo | U-674 |
| 9265720 | Feb 25, 2031 | in 4 yr 9 mo | U-674 |

